SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Cellular Biomedicine Group, Inc. (CBMG)

Uplisting & IPO and forward split.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
konshe Member Profile
 
Followed By 118
Posts 12,312
Boards Moderated 2
Alias Born 01/06/05
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/27/2017 9:31:49 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/22/2017 9:01:13 AM
Cellular Biomedicine Group Plans Grand Opening of its New Shanghai Facility "GlobeNewswire Inc." - 9/22/2017 8:40:00 AM
BioLife Solutions CryoStor® Cell Freeze Media Embedded in Cellular Biomedicine Group Clinical Trial of AlloJoin™ "PR Newswire (US)" - 9/19/2017 6:30:00 AM
Cellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare Conference "GlobeNewswire Inc." - 9/14/2017 8:30:00 AM
Cellular Biomedicine Group Reports Second Quarter and First Half 2017 Financial Results and Business Highlights "GlobeNewswire Inc." - 8/8/2017 4:31:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/8/2017 9:07:08 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/3/2017 6:02:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/28/2017 4:19:36 PM
Cellular Biomedicine Group Appoints Michael A. Caligiuri, MD as Chair of External Advisory Board "GlobeNewswire Inc." - 6/20/2017 6:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/7/2017 11:59:31 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/1/2017 6:08:10 AM
Cellular Biomedicine Group (CBMG) Announces Stock Repurchase Program "GlobeNewswire Inc." - 6/1/2017 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/19/2017 8:31:43 AM
Cellular Biomedicine Group (CBMG) Announces Publication Titled “Target cell killing effects of CD20 targeting chimeric anti... "GlobeNewswire Inc." - 5/19/2017 8:28:42 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/15/2017 2:04:21 PM
Cellular Biomedicine Group (CBMG) Announces the Addition of a Second Clinical Site in the Expansion of its Chimeric Antigen R... "GlobeNewswire Inc." - 5/15/2017 6:23:04 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/8/2017 4:05:05 PM
Cellular Biomedicine Group Reports First Quarter 2017 Financial Results and Provides Business Highlights "GlobeNewswire Inc." - 5/8/2017 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/5/2017 2:11:58 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/1/2017 4:04:01 PM
Cellular Biomedicine Group Announces Results of 2017 Annual Meeting of Stockholders "GlobeNewswire Inc." - 5/1/2017 4:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/10/2017 2:42:24 PM
Cellular Biomedicine Group (CBMG) and GE Healthcare Life Sciences China Announce Strategic Partnership to Establish Joint Tec... "GlobeNewswire Inc." - 4/10/2017 8:05:30 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2017 7:37:31 PM
konshe   Tuesday, 06/11/13 01:11:39 PM
Re: None
Post # of 2734 


Uplisting & IPO and forward split.

Chinese companies recently going to IPO in US stock market are very hot again. I heard two companies PPS have jumped 50%+ In IPO first day. More companies will follow it to IPO In US Stock market. CBMG will be up listing to NASDAQ, this looks like Similar IPO. If Institutional investors are coming in to buy CBMG, the PPS could have big jump In the first up-listing day, because of very low float. After up listing, We could see forward split ( 1 for 2 or 1 for any), because off huge demand and only 2 mm float. Long share holders will get big gain finally. Good luck for 5 years holders.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist